Case number 1:23-cv-00362
AbbVie, Inc. v. Teva Pharmaceuticals, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 3, 2024 | 14 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (Attachments: # 1 Order)(nms) (Entered: 01/03/2024) (0) |
| Jan 2, 2024 | 13 | SO ORDERED Granting 12 Stipulation and Proposed Order of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 1/2/2024. (nms) (Entered: 01/02/2024) (4) |
| Dec 22, 2023 | 12 | STIPULATION of Dismissal by AbbVie Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (4) |
| Jul 24, 2023 | 11 | ANSWER to 9 Answer to Complaint and Counterclaims, by AbbVie Inc..(Tigan, Jeremy) Modified on 7/24/2023 (nms). (Entered: 07/24/2023) (6) |
| Jul 3, 2023 | 9 | ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against AbbVie Inc. by Teva Pharmaceuticals, Inc..(Hoeschen, Nathan) (Entered: 07/03/2023) (15) |
| Jul 3, 2023 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals, Inc. filed by Teva Pharmaceuticals, Inc.. (Hoeschen, Nathan) (Entered: 07/03/2023) (1) |
| May 19, 2023 | 8 | SO ORDERED Granting 7 Stipulation and Proposed Order (*Reset Answer Deadlines: Teva Pharmaceuticals, Inc. answer due 7/3/2023). Signed by Judge Richard G. Andrews on 5/19/2023. (nms) (Entered: 05/19/2023) (5) |
| May 18, 2023 | 7 | STIPULATION and [Proposed] Order Regarding Teva Defendants by AbbVie Inc.. (Tigan, Jeremy) (Entered: 05/18/2023) (5) |
| May 4, 2023 | 6 | MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Roscetti, Danielle A. Duszczyszyn, William B. Raich, Constance P. Lee, Ryan V. McDonnell and Reinaldo Franqui Machin - filed by AbbVie Inc.. (Tigan, Jeremy) (Entered: 05/04/2023) (10) |
| May 4, 2023 | N/A | SO ORDERED, re (D.I. 6 in 23-cv-362-RGA; D.I. 8 in 23-cv-133-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Roscetti, Danielle A. Duszczyszyn, William B. Raich, Constance P. Lee, Ryan V. McDonnell and Reinaldo Franqui Machin, filed by AbbVie Inc.. Signed by Judge Richard G. Andrews on 5/4/2023. Associated Cases: 1:23-cv-00133-RGA, 1:23-cv-00362-RGA(nms) (Entered: 05/04/2023) (0) |
| Apr 5, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00362-RGA, 1:23-cv-00374-RGA (rjb) (Entered: 04/05/2023) (0) |
| Mar 30, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4101417.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jdb) (Entered: 03/30/2023) (Main Document) (16) |
| Mar 30, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jdb) (Entered: 03/30/2023) (3) |
| Mar 30, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/14/2023. Date of Expiration of Patent: 07/23/2039.Thirty Month Stay Deadline: 1/23/2026. (jdb) (Entered: 03/30/2023) (1) |
| Mar 30, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (jdb) (Entered: 03/30/2023) (1) |
| Mar 30, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (jdb) (Entered: 03/30/2023) (1) |
| Mar 30, 2023 | N/A | No Summons Issued. (jdb) (Entered: 03/30/2023) (0) |
| Mar 30, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4101417.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jdb) (Entered: 03/30/2023) (Exhibit A) (30) |
| Mar 30, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4101417.) - filed by AbbVie Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jdb) (Entered: 03/30/2023) (Civil Cover Sheet) (2) |
